Open-label trial to evaluate the efficacy of pre-emptive therapy with minocycline and multidisciplinary intervention for skin toxicity of anti EGFR antibody in colorectal cancer patient
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2625494
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Minocycline tablet 100mg once a day after dinner (for 4 weeks after the day starting to take anti EGFR antibody)
Primary outcome(s): The incidence of >= Grade 2 skin toxicity (Dermatitis acneiform, Paronychia, Dry skin, Pruritus) during 4weeks after starting anti EGFR antibody (using CTCAE v4.0)
Study Design: Single arm Non-randomized
创建时间：
2013-04-15
